Paydirt
EIKN
Ticker

Eikon Therapeutics, Inc.

EIKN · Healthcare · Eikon Therapeutics, Inc., operates as a clinical biopharmaceutical company in the United States

Eikon Therapeutics, Inc. (EIKN), in the Healthcare sector, has 6 disclosed filings on Paydirt over the trailing twelve months from 4 corporate insiders: 6 purchases and 0 sales. Filers took a median of 2 days from execution to disclosure, and the most recent trade was executed Sep 3 and filed Sep 8. The most active filer was Column Group IV GP, LP with 2 filings.

Add to watchlist
Filings, ttm
6
6 buys · 0 sells
Traders, ttm
4
4 insiders
Volume, ttmiDollar value disclosed in the window
$52.2M
estimated for Congress, as filed for insiders
Median delay
2d
execution to disclosure
Last traded
Sep 3
Filed Sep 8
ADViAverage daily dollar volume
$4.4M
market data
Share price · 12M
$9.36 (-37.6%)
$16.26$12.31$8.36Feb 5May 27Sep 14

Adjusted for splits and dividends.

Volume by month
$51.1M$25.6M$0Oct 2024Apr 2025Oct 2025Apr 2026Feb 2026 · buys $51.1MSep 2026 · buys $1.0M
Buys $52.2M Sells $0

Estimated for Congress, as filed for insiders · by filing month · past 24 months

Who filed
CL Column Group IV GP, LP 10% owner 2 filings JW Josh Wolfe Director 2 filings KF Kenneth C Frazier Director 1 filing FL Foresite Capital Management IV, LLC 10% owner 1 filing
Recent filings
Column Group IV GP, LPPURCHASE 10% owner $1.0M
89,200 sh × $11.56
Exec Sep 3
Filed Sep 8 · 4:33 PM ET Column Group IV GP, LPPURCHASE 10% owner $38.1M
2,117,760 sh across 3 lots
Exec Feb 6
Filed Feb 9 · 9:19 PM ET Foresite Capital Management IV, LLCPURCHASE 10% owner $1000K
55,555 sh × $18.00
Exec Feb 4
Filed Feb 6 · 7:37 PM ET Kenneth C FrazierPURCHASE Director $2.0M
111,111 sh × $18.00
Exec Feb 4
Filed Feb 6 · 6:33 PM ET Josh WolfePURCHASE Director $5.0M
277,776 sh across 2 lots
Exec Feb 4
Filed Feb 6 · 6:27 PM ET Josh WolfePURCHASE Director $5.0M
277,776 sh across 2 lots
Exec Feb 4
Filed Feb 6 · 6:25 PM ET